Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
about
Advances in drug delivery system for platinum agents based combination therapyProposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA)Ups and downs of Viagra: revisiting ototoxicity in the mouse model.ACEMg Diet Supplement Modifies Progression of Hereditary Deafness.A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administrationWR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs.A radical demise. Toxins and trauma share common pathways in hair cell death.Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes.Human melanocyte biology, toxicology, and pathology.Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluationBlood flow-independent accumulation of cisplatin in the guinea pig cochlea.Mechanisms of cisplatin ototoxicity: theoretical review.Treatment of head and neck cancer in the elderly.Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?Glial cell line-derived neurotrophic factor. Potential for otoprotection.ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoringDevelopment and validation of a cisplatin dose-ototoxicity model.Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.Hearing impairment after platinum-based chemotherapy in childhood.Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.Protection and spontaneous recovery from cisplatin-induced hearing loss.ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin.Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue.Protective effects of vitamins E, B and C and L-carnitine in the prevention of cisplatin-induced ototoxicity in rats.Development of the middle ear in neonatal chinchillas. I. Birth to 14 days.Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids.Long term hearing degeneration after platinum-based chemotherapy in childhood.Perinatal cisplatin exposure induces cochlear apoptosis in newborn guinea pigs.Study of the protective effect of dexamethasone on cisplatin-induced ototoxicity in rats.Cytoprotective activities of water-soluble fullerenes in zebrafish models
P2860
Q26771390-318DE5FC-F697-481E-8066-92D206F2AA68Q27342479-2A3382C5-8525-4CC2-A6BE-6A3B36475DF9Q28535147-FE1A23B8-F43B-4C06-9259-0E8F887AD08EQ30388543-94D73344-3D47-41CC-BF83-E7C4E6ADC00EQ30411180-0B6FA1B2-3111-4F6C-85FC-D19C93906635Q30492649-308FBF31-30DD-4AE3-A01B-A1F3417D33A6Q30493005-29960A13-4FEC-4987-8DC9-7D7443BD69FAQ33936904-2532EB38-7340-4633-8CB3-1E457B45E01EQ34046822-D621AE6C-E6A8-417C-A1DD-275D7D83D619Q35137650-7D03A8DC-E1A2-4299-9DCE-86EC36E5B93DQ36314397-EA3E8E33-A134-4EF6-AC99-33556B249691Q36753313-A6EDFBFC-97E9-48FF-9348-6D5940A31E69Q36847292-AB09DC7E-58D1-457A-852B-EDDC1EDFAC34Q38104833-4E060A02-4C2B-4DF5-8D1B-FB3F7908B089Q38958367-6EEFA26E-2617-435E-B60B-F7BF41DB9530Q39748993-57A229DE-67CE-4727-B3A2-29C46E0C3C54Q40875441-F5E0CAB0-8A92-4448-B4E9-4131CB017A58Q41322067-737CBC2B-94DB-4010-9D03-B492BE030534Q41322086-C5A42C2D-EEBE-42B2-AF1C-A8EA424C1646Q41583477-F914EE9A-52D2-440F-977F-996D37D4159AQ42752371-D49545E2-6959-4460-95CB-8E578E20E5FAQ44242814-143AC9CE-39F9-469E-8EA4-AB3CD483E050Q46565870-BE323532-1161-4220-B1B1-AA36FD62DD82Q48110974-D7777EB6-124E-48AB-9277-B3CA850F6729Q48257346-D3E80CEC-3E6E-47F0-B1F0-5FBF787C13A3Q48575669-B48A5DEB-5153-498B-857E-AB005DD6885CQ50106367-43C94BF7-E1EB-4629-BCEE-93377F545983Q50433219-B9222C7B-5E43-40E6-8AAD-0E0FE9FEA01EQ50436412-B9EBF355-C6C2-4945-A535-24E3DA9F8886Q50438298-02BE5456-28D0-44ED-B9EA-D19AC01E6D04Q51760295-8F1D8F6D-89CF-4722-A053-1B29EE89C6F8Q58232000-989DE3C0-0F91-45AC-B7E3-352D50251B87
P2860
Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
@en
type
label
Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
@en
prefLabel
Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
@en
P1433
P1476
Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
@en
P2093
V G Schweitzer
P356
10.1288/00005537-199304000-00001
P407
P433
P577
1993-04-01T00:00:00Z